Intranasal delivery may produce fewer gastrointestinal side effects due to lower systemic exposure, consistent with findings from intranasal GLP-1 clinical trials
True infections from properly administered peptides remain extremely rare but warrant attention if symptoms develop
This includes: The chemical identity of the substance Whether the substance is identical or nearly identical to an approved drug How the product is marketed and distributed Who the customers are The foreseeable or intended use of the product If a substance is an approved drug molecule and is sold in ways that mirror clinical or consumer demand, regulators may treat it as a drug even if the label says, Research Use Only. This principle has existed for decades
Semaglutide is a clinically developed GLP-1 receptor agonist that has emerged as one of the most effective pharmacological tools for medical weight management
Dont Lose Your Labeling Store semaglutide in its original packaging to protect it from light and to ensure its clearly labeled
It's about understanding your metabolic health, your specific barriers, and building a protocol that addresses your situation directly